Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine
Status: | Active, not recruiting |
---|---|
Conditions: | Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | Any |
Updated: | 9/13/2018 |
Start Date: | June 2008 |
End Date: | June 2019 |
CAM USE and Cancer
RATIONALE: Educating health providers on talking with cancer patients about complementary and
alternative medicine (CAM) may help encourage health providers to talk more often with cancer
patients about the use of CAM.
PURPOSE: This randomized phase III trial is studying how well an education intervention works
in encouraging health providers to talk with cancer patients about the use of CAM.
alternative medicine (CAM) may help encourage health providers to talk more often with cancer
patients about the use of CAM.
PURPOSE: This randomized phase III trial is studying how well an education intervention works
in encouraging health providers to talk with cancer patients about the use of CAM.
OBJECTIVES:
Primary
- Examine the efficacy of an education intervention designed to increase the frequency
with which health providers ask cancer patients about their use of complimentary and
alternative medicine (CAM).
Secondary
- Examine the frequency with which health providers ask about CAM use and referral for CAM
use by health providers.
- Evaluate whether personal CAM use among health providers is related to the frequency of
asking patients about CAM use.
- Assess the frequency and type of CAM use among patients diagnosed with cancer.
OUTLINE: This is a multicenter study. Stratification is based on the number of health
providers at each CCOP component site (< 3 health providers per component site vs 3 to 6
health providers per component site vs 7 to 9 health providers per component site vs 10 or
more health providers per component site). The CCOP component sites are randomized to 1 of 2
intervention groups.
- Arm I (intervention): Health providers receive educational materials comprising a brief
video about communicating with and providing guidance to patients regarding
complimentary and alternative medicine (CAM) and a list of resources they can access to
obtain information about herbs, CAM modalities, and drug/herb interactions.
Approximately 2 weeks after the educational intervention, health providers receive a
follow-up e-mail reminding them to ask patients about CAM use. The e-mail also includes
a brief update regarding current research findings on CAM modalities and drug/herb
interactions.
- Arm II (wait-list): Health providers are enrolled on a wait-list. After 2 months, the
educational materials in arm I are made available to the wait-list health providers.
Health providers in both arms complete questionnaires at baseline and at 2 months to assess
the effectiveness of the educational intervention, personal CAM use, and level of knowledge
about CAM and to determine if they are asking patients about CAM use. Patients of the health
providers also complete questionnaires at the same time points to assess personal CAM use
before and after cancer diagnosis as well as the level of their interaction with health
providers regarding CAM use.
Primary
- Examine the efficacy of an education intervention designed to increase the frequency
with which health providers ask cancer patients about their use of complimentary and
alternative medicine (CAM).
Secondary
- Examine the frequency with which health providers ask about CAM use and referral for CAM
use by health providers.
- Evaluate whether personal CAM use among health providers is related to the frequency of
asking patients about CAM use.
- Assess the frequency and type of CAM use among patients diagnosed with cancer.
OUTLINE: This is a multicenter study. Stratification is based on the number of health
providers at each CCOP component site (< 3 health providers per component site vs 3 to 6
health providers per component site vs 7 to 9 health providers per component site vs 10 or
more health providers per component site). The CCOP component sites are randomized to 1 of 2
intervention groups.
- Arm I (intervention): Health providers receive educational materials comprising a brief
video about communicating with and providing guidance to patients regarding
complimentary and alternative medicine (CAM) and a list of resources they can access to
obtain information about herbs, CAM modalities, and drug/herb interactions.
Approximately 2 weeks after the educational intervention, health providers receive a
follow-up e-mail reminding them to ask patients about CAM use. The e-mail also includes
a brief update regarding current research findings on CAM modalities and drug/herb
interactions.
- Arm II (wait-list): Health providers are enrolled on a wait-list. After 2 months, the
educational materials in arm I are made available to the wait-list health providers.
Health providers in both arms complete questionnaires at baseline and at 2 months to assess
the effectiveness of the educational intervention, personal CAM use, and level of knowledge
about CAM and to determine if they are asking patients about CAM use. Patients of the health
providers also complete questionnaires at the same time points to assess personal CAM use
before and after cancer diagnosis as well as the level of their interaction with health
providers regarding CAM use.
DISEASE CHARACTERISTICS:
- Health provider meeting the following criteria:
- Has regular contact with cancer patients by initially talking with patients,
taking their histories, and conveying pertinent information to their physician at
a participating CCOP site
- Must be actively seeing patients at a participating University of Texas (UT)
MD Anderson Cancer Center Community Clinical Oncology Program (CCOP) site
- Must not be employed at more than one participating CCOP site
- Not a temporary employee
- Patient of a health provider at a participating CCOP site meeting the following
criteria:
- Current diagnosis of cancer including amyloidosis
- Diagnosed at least 1 week ago
- Finished treatment within the past 6 months
- Able to speak or read English
- No prior participation in this study at an earlier assessment
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
We found this trial at
2
sites
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
101 Manning Drive
Chapel Hill, North Carolina 27514
Chapel Hill, North Carolina 27514
(919) 966-0000
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill One of the...
Click here to add this to my saved trials